Mass spectrometry based metabolomics in chemical and nanomaterial risk assessment In this webinar, Mark Viant, Professor of Metabolomics at the University of Birmingham, will introduce the concepts of metabolomics as well as the challenges faced in chemical hazard assessment.
New Metabolomics Biomarker for Heart Failure Philipp Schatz, Metanomics Health GmbH, speaking at Diagnostics & Biomarkers 2015.
Flow Chemistry from Milligrams to Metric Tons Scott May, Eli Lilly & Co, speaking at Flow Chemistry Congress 2014.
Advances in Volatile Analyses for Disease Diagnosis Norman Ratcliffe, University of the West of England, speaking at Advances in Biodetection & Biosensors 2014.
Towards an Exosomes-based Molecular Test for Remission Monitoring of Cancer Michiel Pegtel, VU University Medical Center, speaking at Molecular Medicine Congress 2013.
Guiding Treatment Decisions in Cancer using Protein Biomarker Measurements: from Design to Utility Prof. Stephen Pennington, University College Dublin, speaking at Discovery Chemistry Congress 2013.
Typical Phospho-form Abundance Profile of Cellular ERK Discovered by Quantitative UPLC-MS Wolf Lehmann, German Cancer Research Center, speaking at Systems Biology Europe 2012
Proteomic and Bioinformatic Approaches to the Development of Biomarker Signatures of Clinical Utility for Prostate Cancer: From Discovery to Targeted Verification Stephen Pennington, University College Dublin, speaking at Systems Biology Europe 2012
Recent Progress in Core-shell and Embedded Nanoparticle Technology for Biomarker Separation with Amperometric Sensing at a Boron Doped Diamond Electrode Jeremy Glennon, University College Cork, speaking at European Lab Automation 2012
Microfluidic Systems for the Analysis of Mass-limited Samples Han Gardeniers, University of Twente, speaking at European Lab Automation 2012